Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Cancer Journal (Sudbury, Mass.)
|
January 23, 2013
Potential predictive biomarkers for individualizing treatment for men with castration-resistant prostate cancer
Rhonda L Bitting, Andrew J Armstrong
Endocrine-Related Cancer
|
March 5, 2013
Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer
Rhonda L Bitting, Andrew J Armstrong
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
January 24, 2014
Prognostic, predictive, and surrogate factors for individualizing treatment for men with castration-resistant prostate cancer
Rhonda L Bitting, Andrew J Armstrong
Clinical Medicine Insights. Oncology
|
December 16, 2017
Clinical Characteristics of Patients With Renal Cell Carcinoma and Metastasis to the Thyroid Gland
Gregory Jackson, Nora Fino, Rhonda L Bitting
Current Oncology Reports
|
July 24, 2020
Racial Disparity in Response to Prostate Cancer Systemic Therapies
Rhonda L Bitting, Michael Goodman, Daniel J George
Current Clinical Pharmacology
|
August 25, 2011
Therapy for non-clear cell histologies in renal cancer
Rhonda L Bitting, John Madden, Andrew J Armstrong
Case Reports in Oncology
|
December 28, 2017
Pazopanib and Statin-Induced Rhabdomyolysis
Jennifer M Logue, Bahram Kiani, Rhonda L Bitting
Clinical Medicine Insights. Oncology
|
November 16, 2011
Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T?
Rhonda L Bitting, Andrew J Armstrong, Daniel J George
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
August 1, 2009
The prognosis and treatment of acquired hemophilia: a systematic review and meta-analysis
Rhonda L Bitting, Stephen Bent, Yongmei Li, et al.
Prostate Cancer and Prostatic Diseases
|
November 10, 2020
Management of men with metastatic castration-resistant prostate cancer following potent androgen receptor inhibition: a review of novel investigational therapies
Matthew K Labriola, Saad Atiq, Nathan Hirshman, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Cancer Journal (Sudbury, Mass.)
|
January 23, 2013
Potential predictive biomarkers for individualizing treatment for men with castration-resistant prostate cancer
Rhonda L Bitting, Andrew J Armstrong
Endocrine-Related Cancer
|
March 5, 2013
Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer
Rhonda L Bitting, Andrew J Armstrong
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
January 24, 2014
Prognostic, predictive, and surrogate factors for individualizing treatment for men with castration-resistant prostate cancer
Rhonda L Bitting, Andrew J Armstrong
Clinical Medicine Insights. Oncology
|
December 16, 2017
Clinical Characteristics of Patients With Renal Cell Carcinoma and Metastasis to the Thyroid Gland
Gregory Jackson, Nora Fino, Rhonda L Bitting
Current Oncology Reports
|
July 24, 2020
Racial Disparity in Response to Prostate Cancer Systemic Therapies
Rhonda L Bitting, Michael Goodman, Daniel J George
Current Clinical Pharmacology
|
August 25, 2011
Therapy for non-clear cell histologies in renal cancer
Rhonda L Bitting, John Madden, Andrew J Armstrong
Case Reports in Oncology
|
December 28, 2017
Pazopanib and Statin-Induced Rhabdomyolysis
Jennifer M Logue, Bahram Kiani, Rhonda L Bitting
Clinical Medicine Insights. Oncology
|
November 16, 2011
Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T?
Rhonda L Bitting, Andrew J Armstrong, Daniel J George
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
August 1, 2009
The prognosis and treatment of acquired hemophilia: a systematic review and meta-analysis
Rhonda L Bitting, Stephen Bent, Yongmei Li, et al.
Prostate Cancer and Prostatic Diseases
|
November 10, 2020
Management of men with metastatic castration-resistant prostate cancer following potent androgen receptor inhibition: a review of novel investigational therapies
Matthew K Labriola, Saad Atiq, Nathan Hirshman, et al.
Page
of 5